Profile of epratuzumab and its potential in the treatment of systemic lupus erythematosus

Overview of attention for article published in Drug Design, Development and Therapy, November 2014

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 28 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent…

Grant US-9757458-B2

United States of America